Mater Clinical Trials

Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health.  Clinical trials are an essential component of healthcare.  They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs. 

Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.

Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.

ALT-100-002: Pioneering the Utility of eNAMPT-Reducing Therapies in Acute Respiratory Distress Syndrome [ARDS]/ ventilator-induced lung injury
Trial Status:
Recruiting
|
Contact:
Katherine Jongebloed, Clinical Trial Coordinator
Neuromodulation Using Scanning Ultrasound in Alzheimer’s Disease
Trial Status:
Recruiting
|
Contact:
Caitlin McElligott
A study into the safety and effectiveness of guselkumab in paediatric patients with moderate to severe ulcerative colitis
Trial Status:
Not yet recruiting
|
Contact:
Sharyn Grossman
This study is assessing the safety and effectiveness of a new anti-epileptic drug, called ganaxalone in patients admitted to the Intensive Care Unit with status epilepticus that has failed to respond to two other anti-epileptic medications.  
Trial Status:
Active, not recruiting
|
Contact:
Research Coordinator, Acute Care
The trial is testing a potential new treatment called disitamab vedotin for Muscle-invasive Bladder Cancer.
Trial Status:
Recruiting
|
Contact:
Caitlin Bennett
A Phase 3 clinical study to investigate the use of benralizumab for patients with moderate to very severe chronic obstructive pulmonary disease (COPD)
Trial Status:
Active, not recruiting
|
Contact:
RIO Clinical Trials Unit
Evaluating eptinezumab with a brief educational intervention for prevention of migraine in patients with migraine and medication overuse headache
Trial Status:
Active, not recruiting
|
Contact:
Stevie Anderson
Improve outcomes for women and small babies by improving blood flow to the baby in labour, to alleviate fetal distress.
Trial Status:
Recruiting
|
Contact:
Ridstress2 Team
A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Trial Status:
Recruiting
|
Contact:
RIO Clinical Trials
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with IPF
Trial Status:
Active, not recruiting
|
Contact:
RIO Clinical Trials Unit
Displaying results 41-50 (of 61)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7  >  >|